Hi, I am Grace Lai-Hung Wong, My LiveDNA is 852.6373
 
   
  Home
 
 
 
Dr. Grace Lai-Hung Wong
 
Highest Degree: M.D. in Medicine from The Chinese University of Hong Kong, Hong Kong
 
Institute: The Chinese University of Hong Kong, Hong Kong
 
Area of Interest: Medicine
  •   Hepatology
  •   Gastroenterology
  •   Alimentary Pharmacology and Therapeutics
  •   Antiviral Therapy
 
URL: http://livedna.org/852.6373
 
My SELECTED Publications
1:   Abrigo, J.M., J. Shen, V.W. Wong, D.K. Yeung and G.L.H. Wong et al., 2013. Non-Alcoholic fatty liver disease: Spectral patterns observed from an in vivo phosphorus magnetic resonance spectroscopy study. J. Hepatol. 10.1016/j.jhep.2013.11.018.
CrossRef  |  PubMed  |  Direct Link  |  
2:   Chan, A.Y., E.K. Li, G.L.H. Wong and D.T. Liu, 2006. Cerebellum vasculopathy and normal tension glaucoma in systemic lupus erythematosus: Report of a case and review of the literature. Rheumatol. Int., 27: 101-102.
CrossRef  |  PubMed  |  Direct Link  |  
3:   Chan, F.K., V.W. Wong, B.Y. Suen, J.C. Wu and J.Y. Ching et al., 2007. Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: A double-blind, randomised trial. Lancet, 369: 1621-1626.
CrossRef  |  PubMed  |  Direct Link  |  
4:   Chan, H.L., C.H. Tse, F. Mo, J. Koh and V.W. Wong et al., 2008. High viral load and hepatitis B virus subgenotype Ce are associated with increased risk of hepatocellular carcinoma. J. Clin. Oncol., 26: 177-182.
CrossRef  |  PubMed  |  
5:   Chan, H.L., G.L.H. Wong and V.W. Wong, 2009. A review of the natural history of chronic hepatitis B in the era of transient elastography. Antivir. Ther., 14: 489-499.
PubMed  |  
6:   Chan, H.L., G.L.H. Wong, A.M. Chim, H.Y. Chan, S.H. Chu and V.W. Wong, 2011. Prediction of off-treatment response to lamivudine by serum hepatitis B surface antigen quantification in hepatitis B e antigen-negative patients. Antivir. Ther., 16: 1249-1257.
CrossRef  |  PubMed  |  
7:   Chan, H.L., G.L.H. Wong, C.H. Tse, A.M. Chim and K.K. Yiu et al., 2009. Hepatitis B virus genotype C is associated with more severe liver fibrosis than genotype B. Clin. Gastroenterol. Hepatol., 7: 1361-1366.
CrossRef  |  PubMed  |  Direct Link  |  
8:   Chan, H.L., G.L.H. Wong, C.H. Tse, H.Y. Chan and V.W. Wong, 2011. Viral determinants of hepatitis B surface antigen seroclearance in hepatitis B e antigen-negative chronic hepatitis B patients. J. Infect. Dis., 204: 408-414.
CrossRef  |  PubMed  |  
9:   Chan, H.L., G.L.H. Wong, P.C. Choi, A.W. Chan and A.M. Chim et al., 2009. Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B. J. Viral. Hepat., 16: 36-44.
CrossRef  |  PubMed  |  
10:   Chan, H.L., V.W. Wong, A.M. Chim, G.L.H. Wong, H.Y. Chan and J.J. Sung, 2008. Treatment of patients with chronic hepatitis B who have failed previous antiviral treatment with pegylated interferon alpha2a (40 kda: PEGASYS). Antivir. Ther., 13: 555-562.
PubMed  |  
11:   Chan, H.L., V.W. Wong, A.M. Chim, H.Y. Chan, G.L.H. Wong and J.J. Sung, 2010. Serum HBsAg quantification to predict response to peginterferon therapy of e antigen positive chronic hepatitis B. Aliment. Pharmacol. Ther., 32: 1323-1331.
CrossRef  |  PubMed  |  
12:   Chan, H.L., V.W. Wong, A.M. Chim, P.C. Choi and H.Y. Chan et al., 2007. Virological response to different combination regimes of peginterferon alpha-2b and lamivudine in hepatitis B e antigen positive chronic hepatitis B. Antivir. Ther., 12: 815-823.
PubMed  |  
13:   Chan, H.L., V.W. Wong, A.M. Tse, C.H. Tse and A.M. Chim et al., 2007. Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response. Clin. Gastroenterol. Hepatol., 5: 1462-1468.
CrossRef  |  PubMed  |  Direct Link  |  
14:   Chan, H.L., V.W. Wong, A.Y. Hui, S.W. Tsang and J.L. Chan et al., 2006. Long-Term lamivudine treatment is associated with a good maintained response in severe acute exacerbation of chronic HBeAg-negative hepatitis B. Antivir. Ther., 11: 465-471.
PubMed  |  
15:   Chan, H.L., V.W. Wong, C.H. Tse, A.M. Chim, H.Y. Chan, G.L.H. Wong, and J.J. Sung, 2007. Early virological suppression is associated with good maintained response to adefovir dipivoxil in lamivudine resistant chronic hepatitis B. Aliment. Pharmacol. Ther., 25: 891-898.
CrossRef  |  PubMed  |  Direct Link  |  
16:   Chan, H.L., V.W. Wong, G.L.H. Wong, A.M. Chim, H.Y. Chan and J.J. Sung, 2008. Early hepatitis B virus DNA suppression can predict virologic response to peginterferon and lamivudine treatment. Clin. Gastroenterol. Hepatol., 6: 1022-1026.
CrossRef  |  PubMed  |  
17:   Chan, H.L., V.W. Wong, G.L.H. Wong, A.M. Chim, L.H. Lai and J.J. Sung, 2009. Evaluation of impact of serial hepatitis B virus DNA levels on development of hepatocellular carcinoma. J. Clin. Microbiol., 47: 1830-1836.
CrossRef  |  PubMed  |  
18:   Chan, H.L., V.W. Wong, G.L.H. Wong, C.H. Tse, H.Y. Chan and J.J. Sung, 2010. A longitudinal study on the natural history of serum hepatitis B surface antigen changes in chronic hepatitis B. Hepatology, 52: 1232-1241.
CrossRef  |  PubMed  |  
19:   Chan, S.L., F.K. Mo, V.W. Wong, G.S. Liem and G.L.H. Wong et al., 2012. Use of antiviral therapy in surveillance: Impact on outcome of hepatitis B-related hepatocellular carcinoma. Liver Int., 32: 271-278.
CrossRef  |  PubMed  |  
20:   Chow, D.K., R.W. Leong, L.H. Lai, G.L.H. Wong, W.K. Leung, F.K. Chan and J.J. Sung, 2008. Changes in Crohn's disease phenotype over time in the Chinese population: Validation of the Montreal classification system. Inflamm. Bowel. Dis., 14: 536-541.
PubMed  |  
21:   Dai, C.Y., T.C. Tseng, G.L.H. Wong, J.F. Huang and V.W. Wong et al., 2013. Consolidation therapy for HBeAg-positive Asian chronic hepatitis B patients receiving lamivudine treatment: A multicentre study. J. Antimicrob. Chemother., 68: 2332-2338.
CrossRef  |  PubMed  |  
22:   De Ledinghen, V., V.W. Wong, J. Vergniol, G.L.H. Wong and J. Foucher et al., 2012. Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: Comparison between M and XL probe of FibroScan®. J. Hepatol., 56: 833-839.
CrossRef  |  PubMed  |  
23:   Ding, C., V.W. Wong, K.C. Chow, H.Y. Chan and A.Y. Hui et al., 2006. Quantitative subtyping of hepatitis B virus reveals complex dynamics of YMDD motif mutants development during long-term lamivudine therapy. Antivir. Ther., 11: 1041-1049.
PubMed  |  
24:   Kwok, R., Y.K. Tse, G.L.H. Wong, Y. Ha and A.U. Lee et al., 2013. Systematic review with meta-analysis: Non-Invasive assessment of non-alcoholic fatty liver disease-the role of transient elastography and plasma cytokeratin-18 fragments. Aliment. Pharmacol. Ther. 10.1111/apt.12569.
CrossRef  |  PubMed  |  
25:   Lai, L.H., G.L.H. Wong, D.K. Chow, J.Y. Lau, J.J. Sung and W.K. Leung, 2006. Long-Term follow-up of patients with obscure gastrointestinal bleeding after negative capsule endoscopy. Am. J. Gastroenterol., 101: 1224-1228.
PubMed  |  
26:   Lai, L.H., G.L.H. Wong, J.Y. Lau, J.J. Sung and W.K. Leung, 2007. Initial experience of real-time capsule endoscopy in monitoring progress of the videocapsule through the upper GI tract. Gastrointest. Endosc., 66: 1211-1214.
27:   Lai, LH., G.L.H. Wong, D.K. Chow, J.Y. Lau, J.J. Sung and W.K. Leung, 2006. Inter-Observer variations on interpretation of capsule endoscopies. Eur. J. Gastroenterol. Hepatol., 18: 283-286.
PubMed  |  
28:   Lee, Y.T., L.Y. Lai, A.J. Hui, V.W. Wong and J.Y. Ching et al., 2009. Efficacy of cap-assisted colonoscopy in comparison with regular colonoscopy: A randomized controlled trial. Am. J. Gastroenterol., 104: 41-46.
CrossRef  |  PubMed  |  
29:   Leung, V.Y., J. Shen, V.W. Wong, J. Abrigo and G.L.H. Wong et al., 2013. Quantitative elastography of liver fibrosis and spleen stiffness in chronic hepatitis B carriers: Comparison of shear-wave elastography and transient elastography with liver biopsy correlation. Radiology, 269: 910-918.
CrossRef  |  PubMed  |  
30:   Leung, W.K., J.Y. Lau, B.Y. Suen, G.L.H. Wong and D.K. Chow et al., 2009. Repeat-Screening colonoscopy 5 years after normal baseline-screening colonoscopy in average-risk Chinese: A prospective study. Am. J. Gastroenterol., 104: 2028-2034.
CrossRef  |  PubMed  |  
31:   Li, X.X., G.L.H. Wong, K.F. To, V.W.S. Wong and L.H. Lai et al., 2009. Bacterial microbiota profiling in gastritis without Helicobacter pylori infection or non-steroidal anti-inflammatory drug use. PLoS One, Vol. 4. 10.1371/journal.pone.0007985.
CrossRef  |  Direct Link  |  
32:   Limquiaco, J.L., G.L.H. Wong, V.W. Wong, P.B. Lai and H.L. Chan, 2009. Evaluation of model for end stage liver disease (MELD)-based systems as prognostic index for hepatocellular carcinoma. J. Gastroenterol. Hepatol., 24: 63-69.
CrossRef  |  PubMed  |  
33:   Limquiaco, J.L., J. Wong, V.W. Wong, G.L.H. Wong and C.H. Tse et al., 2009. Lamivudine monoprophylaxis and adefovir salvage for liver transplantation in chronic hepatitis B: A seven-year follow-up study. J. Med. Virol., 81: 224-229.
CrossRef  |  PubMed  |  Direct Link  |  
34:   Liu, G.J., Q. Ji, F. Moriyasu, X.Y. Xie, W. Wang, G.L.H. Wong, M.X. Lin and M.D. Lu, 2013. Value of contrast-enhanced ultrasound using perflubutane microbubbles for diagnosing liver fibrosis and cirrhosis in rats. Ultrasound Med. Biol., 39: 2158-2165.
CrossRef  |  PubMed  |  
35:   Lo, A.O., V.W. Wong, G.L.H. Wong, H.Y. Chan, C.M. Cheung and H.L. Chan, 2013. Efficacy of entecavir switch therapy in chronic hepatitis B patients with incomplete virological response to telbivudine. Antivir. Ther., 8: 671-679.
PubMed  |  
36:   Lui, Y.Y., K.K. Tsoi, V.W. Wong, J.H. Kao and J.L. Hou et al., 2010. Cost-Effectiveness analysis of roadmap models in chronic hepatitis B using tenofovir as the rescue therapy. Antivir. Ther., 15: 145-155.
PubMed  |  
37:   Ong, A., V.W. Wong, G.L.H. Wong and H.L. Chan, 2011. The effect of caffeine and alcohol consumption on liver fibrosis-a study of 1045 Asian hepatitis B patients using transient elastography. Liver Int., 31: 1047-1053.
CrossRef  |  Direct Link  |  
38:   Ong, A., V.W. Wong, G.L.H. Wong, H.Y. Chan, C.H. Tse and H.L. Chan et al., 2011. Management options for lamivudine-resistant chronic hepatitis B patients with suboptimal virological suppression by adefovir. Aliment. Pharmacol. Ther., 34: 972-981.
CrossRef  |  PubMed  |  
39:   Shen, J., H.L. Chan, G.L.H. Wong, A.W. Chan and P.C. Choi et a., 2012. Assessment of non-alcoholic fatty liver disease using serum total cell death and apoptosis markers. Aliment. Pharmacol. Ther., 36: 1057-1066.
CrossRef  |  PubMed  |  
40:   Shen, J., H.L. Chan, G.L.H. Wong, P.C. Choi and A.W. Chan et al., 2012. Non-invasive diagnosis of non-alcoholic steatohepatitis by combined serum biomarkers. J. Hepatol., 56: 1363-1370.
CrossRef  |  PubMed  |  
41:   Sonneveld, M.J., V.W. Wong, A.M. Woltman, G.L.H. Wong and Y. Cakaloglu et al., 2012. Polymorphisms near IL28B and serologic response to peginterferon in HBeAg-positive patients with chronic hepatitis B. Gastroenterology, 142: 513-520.
CrossRef  |  PubMed  |  
42:   Wong, G.L. and V.W. Wong, 2013. Risk prediction of hepatitis B virus-related hepatocellular carcinoma in the era of antiviral therapy. World J. Gastroenterol., 19: 6515-6522.
CrossRef  |  PubMed  |  
43:   Wong, G.L., 2013. Transient elastography: Kill two birds with one stone? World J. Hepatol., 5: 264-274.
CrossRef  |  PubMed  |  
44:   Wong, G.L., H.L. Chan, A.O. Lo, H.Y. Chan, C.H. Tse, A.M. Chim and V.W. Wong, 2013. Serum hepatitis B surface antigen kinetics in severe reactivation of hepatitis e antigen negative chronic hepatitis B patients receiving nucleos(t)ide analogues. Antivir. Ther. 10.3851/IMP2615.
CrossRef  |  PubMed  |  
45:   Wong, G.L., H.L. Chan, C.H. Mak, S.K. Lee and Z.M. Ip et al., 2013. Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients with liver cirrhosis. Hepatology, 58: 1537-1547.
CrossRef  |  Direct Link  |  
46:   Wong, G.L., H.L. Chan, C.K. Wong, C. Leung and C.Y. Chan et al., 2013. Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B. J. Hepatol. 10.1016/j.jhep.2013.09.029.
CrossRef  |  PubMed  |  Direct Link  |  
47:   Wong, G.L., H.L. Chan, H.Y. Chan, C.H. Tse and Y.K. Tse et al., 2013. Accuracy of risk scores for patients with chronic hepatitis B receiving entecavir treatment. Gastroenterology, 144: 933-944.
CrossRef  |  PubMed  |  Direct Link  |  
48:   Wong, G.L., H.L. Chan, P.C. Choi, A.W. Chan and Z. Yu et al., 2014. Non-invasive algorithm of enhanced liver fibrosis and liver stiffness measurement with transient elastography for advanced liver fibrosis in chronic hepatitis B. Aliment. Pharmacol. Ther., 39: 197-208.
CrossRef  |  PubMed  |  
49:   Wong, G.L., H.L. Chan, P.C. Choi, A.W. Chan, A.O. Lo, A.M. Chim and V.W. Wong, 2013. Association between anthropometric parameters and measurements of liver stiffness by transient elastography. Clin. Gastroenterol. Hepatol., 11: 295-302.
CrossRef  |  PubMed  |  Direct Link  |  
50:   Wong, G.L., H.L. Chan, Y.K. Tse, H.Y. Chan, C.H. Tse, A.O. Lo and V.W. Wong, 2013. On-treatment alpha-fetoprotein is a specific tumor marker for hepatocellular carcinoma in patients with chronic hepatitis B receiving entecavir. Hepatology. 10.1002/hep.26739.
CrossRef  |  PubMed  |  
51:   Wong, G.L., H.L. Chan, Z. Yu, H.Y. Chan, C.H. Tse and V.W. Wong, 2013. Liver fibrosis progression in chronic hepatitis B patients positive for hepatitis B e antigen: A prospective cohort study with paired transient elastography examination. J. Gastroenterol. Hepatol., 28: 1762-1769.
CrossRef  |  PubMed  |  Direct Link  |  
52:   Wong, G.L., H.L. Chan, Z. Yu, H.Y. Chan, C.H. Tse and V.W. Wong, 2013. Liver fibrosis progression is uncommon in patients with inactive chronic hepatitis B: A prospective cohort study with paired transient elastography examination. J. Gastroenterol. Hepatol., 28: 1842-1848.
CrossRef  |  PubMed  |  Direct Link  |  
53:   Wong, G.L., J. Vergniol, P. Lo, W.S. Wong and J. Foucher et al., 2013. Non-Invasive assessment of liver fibrosis with transient elastography (FibroScan®): Applying the cut-offs of M probe to XL probe. Ann. Hepatol., 12: 570-580.
PubMed  |  
54:   Wong, G.L.H. and H.L. Chan, 2005. Molecular virology in chronic hepatitis B: Genotypes. Hosp. Med., 66: 13-16.
PubMed  |  
55:   Wong, G.L.H. and H.L. Chan, 2009. Predictors of treatment response in chronic hepatitis B. Drugs, 69: 2167-2177.
CrossRef  |  PubMed  |  Direct Link  |  
56:   Wong, G.L.H. and V.W. Wong, 2011. Medical therapy for primary sclerosing cholangitis. Aliment. Pharmacol. Ther., 34: 1135-1136.
CrossRef  |  Direct Link  |  
57:   Wong, G.L.H. and V.W. Wong, 2012. Commentary: Predicting survival in hepatocellular carcinoma patients. Aliment. Pharmacol. Ther., 36: 680-680.
CrossRef  |  Direct Link  |  
58:   Wong, G.L.H., 2012. How does hepatitis B virus infection react to hepatocellular carcinoma treatment? J. Gastroenterol. Hepatol., 27: 1-2.
CrossRef  |  PubMed  |  Direct Link  |  
59:   Wong, G.L.H., 2013. Update of liver fibrosis and steatosis with transient elastography (Fibroscan). Gastroenterol. Rep., 1: 19-26.
CrossRef  |  
60:   Wong, G.L.H., 2013. Who will have the best response to entecavir? J. Gastroenterol. Hepatol., 28: 5-7.
CrossRef  |  Direct Link  |  
61:   Wong, G.L.H., A.Y. Hui, V.W. Wong, F.K. Chan, J.J. Sung and H.L. Chan, 2005. A retrospective study on clinical features and prognostic factors of biopsy-proven primary biliary cirrhosis in Chinese patients. Am. J. Gastroenterol., 100: 2205-2211.
CrossRef  |  PubMed  |  Direct Link  |  
62:   Wong, G.L.H., C.N. Chong and V.W.S. Wong, 2013. Tertiary prevention of HBV-related HCC in Asia. Curr. Hepatitis Rep., 12: 157-164.
CrossRef  |  Direct Link  |  
63:   Wong, G.L.H., F.M. Law, V.W. Wong, A.Y. Hui, F.K. Chan, J.J. Sung and H.L. Chan, 2008. Health-related quality of life in Chinese patients with primary biliary cirrhosis. J. Gastroenterol. Hepatol., 23: 592-598.
CrossRef  |  PubMed  |  Direct Link  |  
64:   Wong, G.L.H., H.L. Chan, K.K. Yiu, J.W. Lai and V.K. Chan et al., 2013. Meta-Analysis: The association of hepatitis B virus genotypes and hepatocellular carcinoma. Aliment. Pharmacol. Ther., 37: 517-526.
CrossRef  |  PubMed  |  Direct Link  |  
65:   Wong, G.L.H., H.X. Xu and X.Y. Xie, 2009. Detection of focal liver lesions in cirrhotic liver using contrast-enhanced ultrasound. World J. Radiol., 1: 25-36.
66:   Wong, G.L.H., K.K. Yiu, V.W. Wong, K.K. Tsoi and H.L. Chan, 2010. Meta-analysis: Reduction in hepatic events following interferon-alfa therapy of chronic hepatitis B. Aliment. Pharmacol. Ther., 32: 1059-1068.
CrossRef  |  PubMed  |  Direct Link  |  
67:   Wong, G.L.H., K.M. Chow, A.Y.M. Wang and P.K.T. Li, 2004. Anasarca secondary to problems in three organs: One man with three diseases? Nephrol. Dial. Transplant., 19: 1651-1653.
CrossRef  |  Direct Link  |  
68:   Wong, G.L.H., K.W. Au, A.O. Lo, Y.K. Tse, J.Y. Ching, K.F. To and F.K. Chan, 2012. Gastroprotective therapy does not improve outcomes of patients with Helicobacter pylori-negative idiopathic bleeding ulcers. Clin. Gastroenterol. Hepatol., 10: 1124-1129.
CrossRef  |  Direct Link  |  
69:   Wong, G.L.H., L.H. Lai, J.Y. Lau, J.J. Sung and W.K. Leung, 2006. Prolonged esophageal transit during wireless capsule endoscopy: A series of five cases and analysis of risk factors. J. Clin. Gastroenterol., 40: 176-176.
PubMed  |  
70:   Wong, G.L.H., V.W. Wong and H.L. Chan, 2011. Is transient elastography inaccurate in chronic hepatitis B and non-alcoholic fatty liver disease? J. Hepatol., 55: 497-497.
CrossRef  |  PubMed  |  Direct Link  |  
71:   Wong, G.L.H., V.W. Wong, A.M. Chim, K.K. Yiu, S.H. Chu, M.K. Li and H.L. Chan, 2011. Factors associated with unreliable liver stiffness measurement and its failure with transient elastography in the Chinese population. J. Gastroenterol. Hepatol., 26: 300-305.
CrossRef  |  PubMed  |  Direct Link  |  
72:   Wong, G.L.H., V.W. Wong, G.M. Tan, K.I. Ip and W.K. Lai et al., 2008. Surveillance programme for hepatocellular carcinoma improves the survival of patients with chronic viral hepatitis. Liver Int., 28: 79-87.
CrossRef  |  PubMed  |  Direct Link  |  
73:   Wong, G.L.H., V.W. Wong, H.Y. Chan, P.C. Tse and J. Wong et al., 2012. Undetectable HBV DNA at month 12 of entecavir treatment predicts maintained viral suppression and HBeAg-seroconversion in chronic hepatitis B patients at 3 years. Aliment. Pharmacol. Ther., 35: 1326-1335.
CrossRef  |  PubMed  |  Direct Link  |  
74:   Wong, G.L.H., V.W. Wong, P.C. Choi, A.W. Chan and A.M. Chim et al., 2008. Evaluation of alanine transaminase and hepatitis B virus DNA to predict liver cirrhosis in hepatitis B e antigen-negative chronic hepatitis B using transient elastography. Am. J. Gastroenterol., 103: 3071-3081.
CrossRef  |  PubMed  |  
75:   Wong, G.L.H., V.W. Wong, P.C. Choi, A.W. Chan and A.M. Chim et al., 2009. Clinical factors associated with liver stiffness in hepatitis B e antigen-positive chronic hepatitis B patients. Clin. Gastroenterol. Hepatol., 7: 227-233.
CrossRef  |  PubMed  |  Direct Link  |  
76:   Wong, G.L.H., V.W. Wong, P.C. Choi, A.W. Chan and A.M. Chim et al., 2009. Increased liver stiffness measurement by transient elastography in severe acute exacerbation of chronic hepatitis B. J. Gastroenterol. Hepatol., 24 : 1002-1007.
CrossRef  |  PubMed  |  Direct Link  |  
77:   Wong, G.L.H., V.W. Wong, P.C. Choi, A.W. Chan and A.M. Chim et al., 2009. Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B. Gut, 58: 111-117.
CrossRef  |  PubMed  |  
78:   Wong, G.L.H., V.W. Wong, P.C. Choi, A.W. Chan and A.M. Chim et al., 2011. On-Treatment monitoring of liver fibrosis with transient elastography in chronic hepatitis B patients. Antivir. Ther., 16: 165-172.
CrossRef  |  PubMed  |  
79:   Wong, G.L.H., V.W. Wong, P.C. Choi, A.W. Chan and H.L. Chan, 2010. Development of a non-invasive algorithm with transient elastography (Fibroscan) and serum test formula for advanced liver fibrosis in chronic hepatitis B. Aliment. Pharmacol. Ther., 31: 1095-1103.
CrossRef  |  PubMed  |  Direct Link  |  
80:   Wong, G.L.H., V.W. Wong, P.C. Choi, A.W. Chan and R.H. Chum et al., 2008. Assessment of fibrosis by transient elastography compared with liver biopsy and morphometry in chronic liver diseases. Clin. Gastroenterol. Hepatol., 6: 1027-1035.
CrossRef  |  PubMed  |  
81:   Wong, G.L.H., V.W. Wong, Y. Chan, J.Y. Ching and K. Au et al., 2009. High incidence of mortality and recurrent bleeding in patients with Helicobacter pylori-negative idiopathic bleeding ulcers. Gastroenterology, 137: 525-531.
CrossRef  |  PubMed  |  Direct Link  |  
82:   Wong, J.S., G.L.H. Wong, A.W. Chan, W.V. Wong and Y.S. Cheung et al., 2013. Liver stiffness measurement by transient elastography as a predictor on posthepatectomy outcomes. Ann. Surg., 257: 922-928.
CrossRef  |  PubMed  |  
83:   Wong, J.S., G.L.H. Wong, K.K. Tsoi, V.W. Wong and S.Y. Cheung et al., 2011. Meta-analysis: The efficacy of anti-viral therapy in prevention of recurrence after curative treatment of chronic hepatitis B-related hepatocellular carcinoma. Aliment. Pharmacol. Ther., 33: 1104-1112.
CrossRef  |  PubMed  |  Direct Link  |  
84:   Wong, V.W., A.M. Chim, G.L.H. Wong, J.J. Sung and H.L. Chan, 2007. Performance of the new MELD-Na score in predicting 3-month and 1-year mortality in Chinese patients with chronic hepatitis B. Liver Transpl., 13: 1228-1235.
CrossRef  |  PubMed  |  Direct Link  |  
85:   Wong, V.W., A.Y. Hui, S.W. Tsang, J.L. Chan and A.M. Tse et al., 2006. Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease. Clin. Gastroenterol. Hepatol., 4: 1154-1161.
CrossRef  |  PubMed  |  Direct Link  |  
86:   Wong, V.W., A.Y. Hui, S.W. Tsang, J.L. Chan and G.L.H. Wong et al., 2006. Prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non-alcoholic fatty liver disease. Aliment. Phar. Ther., 24: 1215-1222.
PubMed  |  
87:   Wong, V.W., C.H. Tse, T.T. Lam, G.L.H. Wong and A.M. Chim et al., 2013. Molecular characterization of the fecal microbiota in patients with nonalcoholic steatohepatitis: A longitudinal study. PLoS One, Vol. 8. 10.1371/journal.pone.0062885.
CrossRef  |  PubMed  |  
88:   Wong, V.W., G.L. Wong, J. Yu, P.C. Choi and A.W. Chan et al., 2010. Interaction of adipokines and hepatitis B virus on histological liver injury in the chinese. Am. J. Gastroenterol., 105: 132-138.
PubMed  |  
89:   Wong, V.W., G.L. Wong, P.C. Choi, A.W. Chan and M.K. Li et al., 2010. Disease progression of non-alcoholic fatty liver disease: A prospective study with paired liver biopsies at 3 years. Gut, 59: 969-974.
CrossRef  |  
90:   Wong, V.W., G.L.H. Wong, A.M. Chim, A.M. Tse and S.W. Tsang et al., 2008. Validation of the NAFLD fibrosis score in a Chinese population with low prevalence of advanced fibrosis. Am. J. Gastroenterol., 103: 1682-1688.
CrossRef  |  PubMed  |  
91:   Wong, V.W., G.L.H. Wong, A.M. Chim, P.C. Choi and A.W. Chan et al., 2009. Surrogate end points and long-term outcome in patients with chronic hepatitis B. Clin. Gastroenterol. Hepatol., 7: 1113-1120.
CrossRef  |  PubMed  |  Direct Link  |  
92:   Wong, V.W., G.L.H. Wong, A.M. Chim, T.F. Cheng and S.W. Cheung et al., 2014. Targeted hepatitis C screening among ex-injection drug users in the community. J. Gastroenterol. Hepatol., 29: 116-120.
CrossRef  |  PubMed  |  Direct Link  |  
93:   Wong, V.W., G.L.H. Wong, A.M. Chim, W.C. Chu, D.K. Yeung, K.C. Li and H.L. Chan, 2013. Treatment of nonalcoholic steatohepatitis with probiotics. A proof-of-concept study. Ann. Hepatol., 12: 256-262.
PubMed  |  
94:   Wong, V.W., G.L.H. Wong, A.W. Chan, W.C. Chu and P.C. Choi et al., 2013. Treatment of nonalcoholic steatohepatitis with Phyllanthus urinaria: A randomized trial. J. Gastroenterol. Hepatol., 28 : 57-62.
CrossRef  |  PubMed  |  Direct Link  |  
95:   Wong, V.W., G.L.H. Wong, C.H. Tse, L.K. Yuen, H.Y. Chan, S.A. Locarnini and H.L. Chan, 2012. Antiviral drug resistance testing in patients with chronic hepatitis B. Dig. Dis. Sci., 57: 221-231.
CrossRef  |  PubMed  |  Direct Link  |  
96:   Wong, V.W., G.L.H. Wong, G.W. Yip, A.O. Lo and J. Limquiaco et al., 2011. Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease. Gut, 60: 1721-1727.
CrossRef  |  PubMed  |  
97:   Wong, V.W., G.L.H. Wong, K.K. Yan, A.M. Chim and H.Y. Chan et al., 2010. Durability of peginterferon alfa-2b treatment at 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B. Hepatology, 51: 1945-1953.
CrossRef  |  PubMed  |  Direct Link  |  
98:   Wong, V.W., G.L.H. Wong, K.K. Yiu, A.M. Chim and S.H. Chu et al., 2011. Entecavir treatment in patients with severe acute exacerbation of chronic hepatitis B. J. Hepatol., 54: 236-242.
CrossRef  |  PubMed  |  Direct Link  |  
99:   Wong, V.W., G.L.H. Wong, S.W. Tsang, A.Y. Hui and A.M. Chim et al., 2008. Long-term follow-up of lamivudine treatment in patients with severe acute exacerbation of hepatitis B e antigen (HBeAg)-positive chronic hepatitis B. Antivir. Ther., 13: 571-579.
PubMed  |  
100:   Wong, V.W., G.L.H. Wong, S.W. Tsang, A.Y. Hui and A.W. Chan et al., 2008. Genetic polymorphisms of adiponectin and tumor necrosis factor-alpha and nonalcoholic fatty liver disease in Chinese people. J. Gastroenterol. Hepatol., 23: 914-921.
CrossRef  |  PubMed  |  
101:   Wong, V.W., G.L.H. Wong, S.W. Tsang, A.Y. Hui and A.W. Chan et al., 2009. Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels. Aliment. Pharmacol. Ther., 29: 387-396.
CrossRef  |  PubMed  |  Direct Link  |  
102:   Wong, V.W., G.L.H. Wong, S.W. Tsang, T. Fan and W.C. Chu et al., 2011. High prevalence of colorectal neoplasm in patients with non-alcoholic steatohepatitis. Gut, 60: 829-836.
CrossRef  |  PubMed  |  
103:   Wong, V.W., G.L.H. Wong, W.C. Chu, A.M. Chim and A. Ong et al., 2012. Hepatitis B virus infection and fatty liver in the general population. J. Hepatol., 56: 533-540.
CrossRef  |  PubMed  |  Direct Link  |  
104:   Wong, V.W., J. Vergniol, G.L. Wong, J. Foucher and H.L. Chan et al., 2010. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology, 51: 454-462.
PubMed  |  
105:   Wong, V.W., J. Vergniol, G.L.H. Wong, J. Foucher and A.W. Chan et al., 2012. Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease. Am. J. Gastroenterol., 107: 1862-1871.
CrossRef  |  PubMed  |  
106:   Wong, V.W., J. Yu, A.S. Cheng, G.L. Wong and H.Y. Chan et al., 2009. High serum interleukin-6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B. Int. J. Cancer, 124: 2766-2770.
CrossRef  |  PubMed  |  Direct Link  |  
107:   Wong, V.W., R.S. Chan, G.L.H. Wong, B.H. Cheung and W.C. Chu et al., 2013. Community-Based lifestyle modification programme for non-alcoholic fatty liver disease: A randomized controlled trial. J. Hepatol., 59: 536-542.
CrossRef  |  PubMed  |  Direct Link  |  
108:   Wong, V.W., S.L. Chan, F. Mo, T.C. Chan and H.H. Loong et al., 2010. Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers. J. Clin. Oncol., 28: 1660-1665.
CrossRef  |  PubMed  |  
109:   Wong, V.W., W.C. Chu, G.L.H. Wong, R.S. Chan and A.M. Chim et al., 2012. Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: A population study using proton-magnetic resonance spectroscopy and transient elastography. Gut, 61: 409-415.
CrossRef  |  PubMed  |  
110:   Wong, V.W.S., G.L.H. Wong and F.K.L. Chan, 2013. Liver stiffness measurement: Simplicity is prerequisite for reliability. Gastroenterology, 144: 243-244.
CrossRef  |  Direct Link  |  
111:   Wu, J.C., L.H. Lai, D.K. Chow, G.L.H. Wong, J.J. Sung and F.K. Chan, 2011. Concomitant irritable bowel syndrome is associated with failure of step-down on-demand proton pump inhibitor treatment in patients with gastro-esophageal reflux disease. Neurogastroenterol. Motil., 23: 155-160.
CrossRef  |  PubMed  |  
112:   Yan, K.K., G.L.H. Wong, V.W. Wong and H.L. Chan, 2010. Rate and factors affecting treatment uptake of patients with chronic hepatitis C in a tertiary referral hospital. Dig. Dis. Sci., 55: 3541-3547.
CrossRef  |  PubMed  |  Direct Link  |  
113:   Yu, Z., G.L.H. Wong and V.W. Wong, 2012. Commentary: Time to update the ALT cut-off? Aliment. Pharmacol. Ther., 36: 682-683.
CrossRef  |  Direct Link  |  
114:   Yu, Z., V.W. Wong and G.L.H. Wong, 2012. Non-Invasive algorithms for liver fibrosis. Aliment. Pharmacol. Ther., 35: 310-311.
CrossRef  |  Direct Link  |